Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed

He Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3275-7393; OpenAlex author ID A5101887356. Sources: OpenAlex.

Their work

Papers
13 (first author 3, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
29
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 3 papers · 2015: 3 papers · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: 2 papers

Papers 13

  1. RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2019.03.036↗
  2. Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1084/jem.20180749↗
  3. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of … Last author DOI 10.1053/j.gastro.2017.09.039↗
  4. ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin. Co-author DOI 10.1158/0008-5472.can-16-2170↗
  5. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer. Last author DOI 10.3390/ijms18040622↗
  6. Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.canlet.2016.05.016↗
  7. Wnt2 protein plays a role in the progression of pancreatic cancer promoted by pancreatic stellate cells. Co-author DOI 10.1007/s12032-015-0513-2↗
  8. Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma. First author DOI 10.18632/oncotarget.2948↗
  9. Integrated microRNA-mRNA analysis of pancreatic ductal adenocarcinoma. Last author DOI 10.4238/2015.august.28.14↗
  10. The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer. First author DOI 10.1007/s13277-014-2452-5↗
  11. CypA, a gene downstream of HIF-1α, promotes the development of PDAC. Co-author DOI 10.1371/journal.pone.0092824↗
  12. [Effects of dioscin on apoptosis in pancreatic cancer MiaPaCa-2 cells and its mechanism]. First author PMID 24685079↗
  13. Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene. Co-author DOI 10.1371/journal.pone.0043399↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jihui Hao · 12 shared papers, 2012–2019 · strength 0.69
  2. Xiuchao Wang · 9 shared papers, 2012–2019 · strength 0.52
  3. Tiansuo Zhao · 8 shared papers, 2012–2019 · strength 0.45
  4. Song Gao · 8 shared papers, 2012–2019 · strength 0.44
  5. Chongbiao Huang · 6 shared papers, 2015–2019 · strength 0.36
  6. Shengyu Yang · 4 shared papers, 2016–2019 · strength 0.26
  7. Zengxun Li · 2 shared papers, 2018–2019 · strength 0.16
  8. Xiao Ling Zhao · 3 shared papers, 2014 · strength 0.15
  9. Mingxiao Lang · 2 shared papers, 2016–2019 · strength 0.14
  10. Wenna Jiang · 2 shared papers, 2017–2019 · strength 0.13
  11. Chuntao Gao · 2 shared papers, 2014–2017 · strength 0.11
  12. Liangliang Wu · 1 shared paper, 2019 · strength 0.08
  13. Haotian Wang · 1 shared paper, 2019 · strength 0.08
  14. Ming Yu · 2 shared papers, 2012–2016 · strength 0.08
  15. Danqi Fu · 1 shared paper, 2019 · strength 0.07
  16. Tianxing Zhou · 1 shared paper, 2019 · strength 0.07
  17. Jing Liu · 1 shared paper, 2019 · strength 0.07
  18. Na Li · 1 shared paper, 2018 · strength 0.07
  19. Yu Xu · 1 shared paper, 2017 · strength 0.07
  20. Chao Xu · 1 shared paper, 2017 · strength 0.07
  21. P.F. Liu · 1 shared paper, 2015 · strength 0.06
  22. Keping Xie · 1 shared paper, 2017 · strength 0.06
  23. Yanhui Yang · 1 shared paper, 2016 · strength 0.05
  24. Yong Xu · 1 shared paper, 2015 · strength 0.05
  25. Huan Zhang · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.